Gastrointestinal toxicity associated with weekly docetaxel treatment-Reference-Cited by-同舟云学术

Gastrointestinal toxicity associated with weekly docetaxel treatment

Published:2002-06 Issue:6 Volume:13 Page:978-981
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Stemmler H.J.,Kenngott S.,Diepolder H.,Heinemann V.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/6/978/586815/mdf084.pdf

Reference21 articles.

1. Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer;Chan;J Clin Oncol,1999

2. Efficacy and safety of docetaxel (Taxotere™) in heavily pretreated advanced breast cancer patients;Bonneterre;The French compassionate use programme experience. Eur J Cancer,1999

3. Docetaxel: standard recommended dose of 100 mg/m2 is effective but not feasible for some metastatic breast cancer patients heavily pretreated with chemotherapy. A phase II single-center study;Salminen;J Clin Oncol,1999

4. Weekly schedules of docetaxel;Burris;Semin Oncol,1998

5. Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis;Tomiak;J Clin Oncol,1994

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Docetaxel Injection and Docetaxel Micelles on the Intestinal Barrier and Intestinal Microbiota;Advanced Science;2021-10-28

2. Fever and breast cancer: A critical review of the literature and possible underlying mechanisms;Breast Disease;2021-07-15

3. Neutropenic Enterocolitis and Sepsis: Towards the Definition of a Pathologic Profile;Medicina;2021-06-20

4. Neutropenic enterocolitis-induced sepsis and disseminated intravascular coagulation after chemotherapy: a case report;BMC Women's Health;2021-05-03

5. No relation between docetaxel administration route and high‐grade diarrhea incidence;Pharmacology Research & Perspectives;2020-07-28